...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary
Reply New Message
Prev Message Back To Forum Threaded View Next Message

fouremm, thanks for the clarification on the shares.

I don't suppose he mentioned how our current share value will be portioned after the split, i.e., what percentage will be held in Zenith Epigenetics Ltd and what percentage in Zenith Capital Corp?

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply